We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Mallinckrodt to Acquire Therakos for $1.325B

News   Aug 11, 2015

 
Mallinckrodt to Acquire Therakos for $1.325B
 
 
 

RELATED ARTICLES

Drug Targets Early Instigator of Alzheimer's Disease

News

Therapeutic efforts to target "plaques and tangles", considered classic hallmarks of Alzheimer's disease, have previously met with dispiriting failure. Now researchers are exploring a drug called "DYR219" – its strength lies in the fact that it can target both plaques and tangles.

READ MORE

World-first: Genetically Modified Miniature Human Livers Are Grown in the Laboratory

News

Researchers are the first to grow genetically modified miniature human livers in the laboratory, to emulate human liver disease progression and test therapeutics.

READ MORE

Decoding Pancreatic Cancer’s Invade and Evade Tactics

News

Two known gene mutations induce pathways that enhance pancreatic cancer's ability to invade tissues and evade the immune system. Researchers now report on the molecular details of this process, shining a light on potential druggable targets for immunotherapies.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE